Sequencing rare and common APOL1 coding variants to determine kidney disease risk.
Limou, Sophie; Nelson, George W; Lecordier, Laurence; An, Ping; O'hUigin, Colm S; David, Victor A; Binns-Roemer, Elizabeth A; Guiblet, Wilfried M; Oleksyk, Taras K; Pays, Etienne; Kopp, Jeffrey B; Winkler, Cheryl A.
; 88(4): 754-63, 2015 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-25993319
APOL1 and kidney disease.
APOL1 variants associate with increased risk of CKD among African Americans.
APOL1 variants increase risk for FSGS and HIVAN but not IgA nephropathy.
APOL1 genetic variants in focal segmental glomerulosclerosis and HIV-associated nephropathy.
Interventions for HIV-associated nephropathy.
HIV-associated nephropathy in the setting of maximal virologic suppression.
NPHS2 variation in sporadic focal segmental glomerulosclerosis.
Recent progress in HIV-associated nephropathy.
HIV-associated nephropathy: clinical presentation, pathology, and epidemiology in the era of antiretroviral therapy.
APOL1 localization in normal kidney and nondiabetic kidney disease.